Shopping Cart
- Remove All
- Your shopping cart is currently empty
Seviteronel (VT-464) is a novel CYP17 cleavage enzyme inhibitor and androgen receptor antagonist used in breast and prostate cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $113 | In Stock | |
5 mg | $273 | In Stock | |
10 mg | $396 | In Stock | |
25 mg | $675 | In Stock | |
50 mg | $959 | In Stock | |
100 mg | $1,280 | In Stock |
Description | Seviteronel (VT-464) is a novel CYP17 cleavage enzyme inhibitor and androgen receptor antagonist used in breast and prostate cancer research. |
Targets&IC50 | CYP17 Lyase (human):69 nM |
In vitro | Seviteronel (VT-464) selectively inhibits CYP17 17,20-lyase to suppress androgen production without causing mineralocorticoid excess or cortisol depletion[2]. |
In vivo | Seviteronel(100 mg/kg bid; oral administration for 25 days) reduced tumor volume in castrated male mice with xenografts[2]. |
Alias | VT-464 |
Molecular Weight | 399.34 |
Formula | C18H17F4N3O3 |
Cas No. | 1610537-15-9 |
Smiles | CC(C)[C@@](O)(c1c[nH]nn1)c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1 |
Relative Density. | 1.393 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (100.16 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.